Status:

ACTIVE_NOT_RECRUITING

A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

Lead Sponsor:

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Conditions:

Myopia

Eligibility:

All Genders

6-12 years

Phase:

PHASE3

Brief Summary

A randomized, double-blind, placebo-controlled, multicenter, phase III clinical study of the efficacy and safety of two low-concentration atropine sulfate eye drops in slowing the progression of myopi...

Detailed Description

Primary objective is to evaluate the efficacy and safety of atropine sulfate eye drops versus placebo for 12 months in slowing the progression of myopia in children. The study was designed to enroll ...

Eligibility Criteria

Inclusion

  • Child (female or male) aged 6 to 12 years.
  • Myopia (SER of at least -0.50 D and no more myopic than -6.00 D) in each eye as measuredby cycloplegic autorefraction.
  • If present, astigmatism of ≤1.50 D in each eye as measured by cycloplegic autorefraction.
  • Anisometropia SER of \< 1.50 D as measured by cycloplegic autorefraction.

Exclusion

  • Have used other myopia control methods other than those used in this study, such as instruments (orthokeratology lenses, multifocal glasses, progressive glasses), drugs (atropine, etc.); Only single vision glasses are allowed for myopia correction;
  • Have used myopic control methods such as traditional Chinese medicine, auricular acupuncture, massage, and reverse beat within 30 days before screening;
  • Use of any local or systemic antimuscarinic/anticholinergic medication (e.g., atropine, scopolamine, tropicamide, phenamine, diphenhydramine, oxytropine, tricyclic antidepressant, etc.) within 21 days before screening; Allowing for tests such as cycloplegic optometry;

Key Trial Info

Start Date :

March 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2025

Estimated Enrollment :

777 Patients enrolled

Trial Details

Trial ID

NCT06209320

Start Date

March 15 2022

End Date

August 1 2025

Last Update

July 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Tongren Hospital, Capital Medical University

Beijing, Beijing Municipality, China